TCA
CC icon

Transcend Capital Advisors’s Chemours CC Stock Holding History

Transcend Capital Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,211
Closed -$231K – 491
2022
Q2 		$231K Hold
7,211
– – 0.02% 424
2022
Q1 		$227K Buy
7,211
+111
+2% +$3.47K 0.02% 450
2021
Q4 		$238K Buy
+7,100
New +$221K 0.02% 421

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Transcend Capital Advisors's CC Position: Q3 2022 in Review

Transcend Capital Advisors sold out of Chemours (CC) in Q3 2022, closing a stake of 7,211 shares — an estimated $231K sold.

Transcend Capital Advisors first reported a position in CC in Q4 2021 and held it in 3 quarters. The position peaked at $238K in Q4 2021. 487 funds tracked by Wall St. Rank hold CC as of Q3 2022.

  • Transcend Capital Advisors reported no remaining Chemours position as of Q3 2022 after selling out during the quarter.
  • Transcend Capital Advisors sold 7,211 Chemours shares in Q3 2022, an estimated $231K.
  • Transcend Capital Advisors first reported a position in Chemours in Q4 2021 and held it in 3 quarters.
  • Transcend Capital Advisors's Chemours position peaked at $238K in Q4 2021.
  • 487 funds tracked by Wall St. Rank held Chemours as of Q3 2022.

Based on Transcend Capital Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.